Drugs / DTPw-HBV/Hib-MenAC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00317161 | Aug 2004 → Apr 2005 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPw-HBV/Hib-MenAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00317161 ↗ |
| Known as | DTPw-HBV/Hib-MenAC conjugate vaccine | “DTPw-HBV/Hib-MenAC conjugate vaccine” NCT00317161 ↗ |
| Modality | Vaccine | “DTPw-HBV/Hib-MenAC conjugate vaccine” NCT00317161 ↗ |